Global Thrombectomy Devices Market Is Estimated to Grow About $2.12 Bn By 2030

The global thrombectomy devices market size was worth around USD 1.35 Billion in 2021 and is estimated to grow to about USD 2.12 Billion by 2030, with a compound annual growth rate (CAGR) of approximately 6.9% over the forecast period.

Thrombectomy devices are technologically advanced products that are essentially used in the removal of blood clots from arteries and veins. Thus, these devices are widely used in the treatment of various diseases such as pulmonary embolism and peripheral arterial diseases. Various products are extensively used to eliminate thrombus from coronary arteries, peripheral arteries, and cerebral arteries.

They particularly include microcatheters, aspiration thrombectomy devices, stent retrievers, and clot extraction catheters. Presently, thrombectomy devices are conveniently obtainable in several diameters and sizes, based on the impacted area. Balloon embolectomy, surgical embolectomy, and aspiration embolectomy are some of the immensely used thrombectomy devices.

The demand for the global thrombectomy devices market is expected to surge exponentially due to a significant surge in demand for stent retrievers as they are mainly used to treat thrombotic diseases. Besides, an increase in the prevalence of various acute diseases such as deep vein thrombosis (DVT), acute myocardial infarction (AMI), pulmonary embolism (PE), and peripheral artery disease (PAD), particularly among the older generation is expected to drive the growth of the market.

In addition, the prevailing demand for minimally invasive procedures, the presence of sedentary & unhealthy lifestyles among the younger generation, the rise in the geriatric population, growing incidences of cardiovascular diseases, the increase in healthcare expenditure, and the prevalence of favorable initiatives from the government and private organization for improved healthcare infrastructure are predicted to drive the growth of the thrombectomy devices industry.

Furthermore, persistent technological advancements in thrombectomy devices and the growing implementation of Artificial Intelligence (AI) in medical devices are anticipated to create remunerative opportunities for the growth of the global thrombectomy devices market. However, a lack of skilled professionals and reduced awareness about thrombectomy devices restrict the growth of the market during the forecast period.

The global thrombectomy devices market is segmented based on thrombectomy devices technology, devices type, utility, diseases, and region.

Based on device type, the market is segmented into manual and automatic. The manual segment held the largest market share in 2021 and is further predicted to grow rapidly at a promising CAGR during the forecast period. The major reason for the growth of this segment is the rise in healthcare expenditure, the prevalence of approving medical reimbursements, a surge in research & development activities in healthcare, and persistent technological advancements for the development of innovatively advanced thrombectomy devices for the rising number of patients related to cardiovascular diseases across the globe.

Based on utility, the market is segmented into reusable devices and disposable devices. The disposable thrombectomy device segment held the largest market share in 2021 and is further expected to occupy a dominant market share and simultaneously grow at a significant CAGR during the forecast period. The major reason for the growth of this segment is its increased application in hospitals and clinics as the chances of contracting and spreading infection with disposable devices are completely eliminated, which results in its increased adoption among healthcare professionals for undertaking various treatments.

Based on region, the North American region held the largest market share in 2021 and is further predicted to occupy the maximum market share during the forecast period. The growth of the thrombectomy devices market in this region is mainly attributed to the prevalence of better and advanced healthcare infrastructure, the rise in the geriatric population, significant growth in the number of surgical procedures, and the rise in the prevalence of cardiovascular & neurological diseases among people living in this region. In addition, the growing number of clinical trials, increased healthcare expenditure, and prevalence of medical reimbursements in the region are expected to drive the growth of the regional thrombectomy devices market.

This review is based on a report by Zion Market Research, titled “Thrombectomy Devices Market By Thrombectomy Devices Technology (Mechanical, Aspiration, and Rheolytic), By Devices Type (Automated and Manual), By Utility (Reusable Devices and Disposable Devices), Diseases (Peripheral, Coronary and Neural), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2030.”- Report at https://www.zionmarketresearch.com/report/thrombectomy-devices-market

Recent Developments:

• In February 2022, Cardiovascular Systems, Inc., an innovative medical device company, announced that they have collaborated with Innova Vascular, Inc., a creative medical devices startup that is involved in developing breakthrough medical devices with a minimally invasive approach, in order to develop an effective line of thrombectomy devices. They strive to develop effective aspiration and mechanical devices to functionally treat various diseases such as deep vein thrombosis, peripheral vascular disease, pulmonary embolism, and others.
• In July 2021, Surmodics, Inc., a dominant provider of in vitro diagnostic technologies and medical devices, announced that they have acquired Vetex Medical Limited, an Ireland-based medical device provider. The acquisition expands Surmodics’ offerings to provide utterly effective mechanical thrombectomy devices which is also U.S. Food and Drug Administration (FDA) cleared. Their devices are specially designed to treat various acute diseases including arterial and venous thrombosis.

The global thrombectomy devices market is dominated by players such as:

• Stryker Corporation
• Medtronic plc.
• Boston Scientific Corporation
• Terumo Corporation
• Penumbra Inc.
• Johnson & Johnson
• Spectranetics Corporation
• Teleflex Incorporated
• AngioDynamics Inc.
• Bayer AG
• Merit Medical Systems
• Phenox Gmbh
• Philips Healthcare
• Straub Medical AG
• Teleflex Incorporated
• Argon Medical Devices Inc.
• Edwards Lifesciences Corporation.

Global thrombectomy devices market is segmented as follows:

By Technology

• Mechanical Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Rheolytic Thrombectomy Devices

By Type

• Automated Devices
• Manual Devices

By Utility

• Reusable Devices
• Disposable Devices

By Diseases

• Peripheral Diseases
• Coronary Diseases
• Neural Diseases

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com